合成,抗癌活性,以及在体研究中对5 - - 3 - 基) - - - N - - -4 - - H - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Mohamed Jawed Ahsan1, Krishna Gautam1, Amena Ali2
1Department of Pharmaceutical Chemistry, Maharishi Arvind College of Pharmacy, Ambabari Circle, Jaipur 302039, Rajasthan, India.
Molecules (Basel, Switzerland)
|October 14, 2023
概括
合成了10种新的三胺类类似物,并对抗癌活性进行了测试. 化合物4i对多种癌细胞系表现出有前途的活性,具有潜在的蛋白抑制和有利的ADME/毒性概况.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 新型抗癌药物的开发对于改善癌症治疗结果至关重要.
- 三胺衍生物已经显示出作为治疗剂的潜力.
- 鉴定具有强大和选择性的抗癌活性的新化合物仍然是一个重大挑战.
研究的目的:
- 为了合成和表征新型的5-(3-甲基) -N--4H-1,2,4-三醇-3-胺类同类物.
- 为了评估这些化合物的体外抗癌活性与人类癌症细胞系的小组相比.
- 研究分子相互作用并预测合成化合物的药理动力学和毒理学概况.
主要方法:
- 通过三步程序合成十种5-(3-甲) -N--4H-1,2,4-三醇-3-胺类型 (4a-j) 的类似物.
- 使用美国国家癌症研究所 (NCI US) 协议对58个癌细胞系进行10−5M的抗癌活性查.
- 分子对接研究的目标是氨酸-combretastatin A-4结合部位 (PDB ID: 5LYJ).
- 使用瑞士ADME和ProTox-II软件进行ADME (吸收,分布,新陈代谢,分泌) 和毒性预测.
主要成果:
- 化合物4a-j已成功合成和表征.
- 几种化合物表现出显著的抗癌活性,其中化合物4e对SNB-75 (中枢神经系统癌症) 显示41.25%的生长抑制.
- 化合物4i在多个细胞系中显示出有希望的平均生长抑制,包括SNB-75 (38.94% PGI),UO-31 (30.14% PGI),CCRF-CEM (26.92% PGI),EKVX (26.61% PGI) 和OVCAR-5 (23.12% PGI).
- 分子对接揭示了有效的结合亲和力 (-6.502到-8.341千卡/mol) 到素结合部位,与化合物4i显示一个结合亲和力 -8.149千卡/mol,并形成一个H键与Asn258.8.
- ADME预测表明没有违反利宾斯基五项规则,毒性预测表明LD50在440-500毫克/公斤之间 (第四类毒性).
结论:
- 合成的5-(3-甲基) -N--4H-1,2,4-三醇-3-胺类同类物具有显著的抗癌潜力.
- 化合物4i是进一步抗癌药物开发的有希望的主要候选者,特别是由于它对各种癌症细胞系的活性和有利的预测特性.
- 这些发现支持氨酸抑制作为一种潜在的作用机制,并需要进一步的体内研究.
相关概念视频
Physical Properties of Amines
3.2K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.2K
Structure-Activity Relationships and Drug Design
737
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
737
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K


